Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBALT: Obeticholic Acid in Primary Biliary Cholangitis
NCT02308111Phase 4Terminated
- Sponsor
- Intercept Pharmaceuticals
- Start
- Dec 2014
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 31
01
Overview
A Phase 4 trial of obeticholic acid in primary biliary cholangitis (PBC), sponsored by Intercept Pharmaceuticals. Started Dec 2014; status: terminated.
02
Drugs
obeticholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02308111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308111.